Table 4 Comparison between patients with favorable and unfavorable outcomes regarding the studied ratios at the various studied sites
Outcome | |||||
|---|---|---|---|---|---|
Favorable N = 10 | Unfavorable N = 20 | T | P value | ||
Basal ganglia | |||||
lac/Cr ratio | Mean ± SD | 0.26 ± .09 | 2.29 ± .82 | 10.96 | < 0.001* |
NAA/Cr ratio | Mean ± SD | 1.02 ± .07 | 0.62 ± .11 | 10.92 | < 0.001* |
NAA/CHO ratio | Mean ± SD | 0.37 ± .03 | 0.2 ± .05 | 9.64 | < 0.001* |
CHO/Cr ratio | Mean ± SD | 2.90 ± .31 | 3.09 ± .25 | 1.82 | 0.079 |
Thalamus | |||||
Lac/Cr ratio | Mean ± SD | 0.26 ± .08 | 2.51 ± .92 | 7.64 | < 0.001* |
NAA/Cr ratio | Mean ± SD | 1.03 ± .06 | 0.62 ± .10 | 13.56 | < 0.001* |
NAA/CHO ratio | Mean ± SD | 0.35 ± .06 | 0.21 ± .05 | 7.26 | < 0.001* |
CHO/Cr ratio | Mean ± SD | 2.91 ± .28 | 3.07 ± .27 | 1.45 | 0.158 |
Frontal WM | |||||
Lac/Cr ratio | Mean ± SD | 0.27 ± .12 | 2.47 ± .82 | 11.75 | < 0.001* |
NAA/Cr ratio | Mean ± SD | 1.07 ± .04 | 0.61 ± .07 | 19.08 | < 0.001* |
NAA/CHO ratio | Mean ± SD | 0.39 ± .04 | 0.21 ± .06 | 8.54 | < 0.001* |
CHO/Cr ratio | Mean ± SD | 2.90 ± .28 | 3.02 ± .20 | 1.41 | 0.169 |
Occipital WM | |||||
Lac/Cr ratio | Mean ± SD | 0.29 ± .08 | 2.54 ± .93 | 10.80 | < 0.001* |
NAA/Cr ratio | Mean ± SD | 1.04 ± .09 | 0.55 ± .14 | 10.0 | < 0.001* |
NAA/CHO ratio | Mean ± SD | 0.37 ± .04 | 0.21 ± .06 | 9.25 | < 0.001* |
CHO/Cr ratio | Mean ± SD | 3.05 ± .26 | 3.10 ± .24 | 0.509 | 0.615 |